KRAS and familial pancreatic carcinoma: Further filtering for kinases led to the discovery of the Phosphatidylinositol 4-Phosphate 5-Kinase Type-1 Alpha as a KRAS G12V selective interactor, which mediated proliferation and resistance to MEK inhibitors in pancreatic cancer cell lines.